GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Molecular Partners MOLN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

2.58

-0.77%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Molecular Partners — daily SIX:MOLN End of day
Market value
CHF 87.8m
Last close × shares
Volume
35.5k
Shares, 9 Nov 2026

About Molecular Partners

Its shares trade on SIX under the ticker MOLN.SW. It has been listed since 22 October 2014. In the fiscal year to 31 December 2024, it reported revenue of CHF 5.0m and a net loss of CHF 54.0m. At that date it held total assets of CHF 158.5m and shareholders' equity of CHF 141.6m.

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich. The company went IPO on 2014-10-22. As a biopharmaceutical company, it is active in the research and development of proteins like DARPins (Designed Ankyrin Repeat Proteins), a new class of small proteins used for the development of medicine against diseases like cancer and sight-threating diseases, among others. The Company’s pipeline is structured mainly through three areas: Ophthalmology, including the creation of therapies for renital diseases like wet age-related macular degeration (wet AMD) and diabetic macular edema (DME); Oncology, containing the development of DARPins against cancer, among others; and Immunology and other Indications, entailing DARPins against several targets important for the treatment of inflammatory and auto-immune diseases.

Figures and description from our data supplier, not checked against the company's own report.

More about Molecular Partners →

Latest on Molecular Partners

Our reporting

Next results

5 Mar 2027

Due on 5 Mar 2027. Analysts expect earnings of -0.36 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Molecular Partners's ticker?

Molecular Partners trades as MOLN.SW on SIX, under ISIN CH0256379097.

What was Molecular Partners's last closing price?

2.58 on 9 Nov 2026. The figure is in CHF and is never converted.

When does Molecular Partners next report results?

Results are expected on 5 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.